Homebout REDIPartnershipActivitiesContact Us

Mission
Governing Board
bullet Administration
Location
News
   

   

PLEASE NOTE: REDI Center officially ended opperations on July 12, 2012. This website is for archival purposes only. Some links may be inactive.

In the wake of SARS, President George W Bush and Prime Minister Goh Chok Tong agreed that a joint US-Singapore facility should be established to tackle emerging and re-emerging infectious diseases and epidemics in the region. After a meeting in May 2003, both leaders released a joint statement that said “that the two countries should explore prospects for collaborative efforts to understand new health threats which put the world community at risk, including tropical diseases and biological warfare agents”. The two leaders announced the initiative to deal with emerging and re-emerging infectious diseases at October 21, 2003, APEC Leaders meeting in Bousai, Korea.

Subsequently, the US Ambassador Mr Franklyn L. Lavin and Acting Health Minister Khaw Boon Wan signed a Memorandum of Understanding to enhance and expand bilateral cooperative efforts in health and medical sciences and in confronting health security threats on October 17, 2003. The REDI Center was officially opened on May 24, 2004 at Singapore’s Biopolis hub for biomedical research. Following that in 2005, both sponsoring economies signed another bilateral agreement. REDI Center was then chartered as an inter-governmental organization in November 2005.

Dr. Kimi Lim served as the first Interim Executive Director of REDI Center in 2004. Dr. Richard M Krause followed Dr. Lim as the Acting Executive Director from 2005-2006. Both Dr. Lim and Dr. Krause made salient contributions to jump start the Center’s mission to the development of training programs to build capacity to address emerging diseases in the region.

Dr. Rodney Hoff was appointed the first Executive Director of the REDI Center in November 2006. For the past few years under Dr. Hoff’s leadership the Center has focused on avian influenza control in Indonesia, infection control in the Cambodia, Laos, Indonesia and Vietnam and training on laboratory biosafety, influenza diagnosis, and outbreak investigation and response and influenza pandemic preparedness.